This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1988 Aug;85(2):279.

Excessive aminoglycoside nephrotoxicity in obese patients

G B Corcoran¹, D E Salazar, J J Schentag

Affiliations

PMID: 3400711

Excessive aminoglycoside nephrotoxicity in obese patients

G B Corcoran et al. Am J Med. 1988 Aug.

. 1988 Aug;85(2):279.

Authors

G B Corcoran¹, D E Salazar, J J Schentag

Affiliation

¹ University of New Mexico, Albuquerque.

PMID: 3400711

No abstract available

PubMed Disclaimer

Similar articles

Aminoglycoside dosing in patients by kidney function and area under the curve: the Sawchuk-Zaske dosing method revisited in the era of obesity.
Pai MP, Rodvold KA. Pai MP, et al. Diagn Microbiol Infect Dis. 2014 Feb;78(2):178-87. doi: 10.1016/j.diagmicrobio.2013.10.011. Epub 2013 Oct 22. Diagn Microbiol Infect Dis. 2014. PMID: 24268292 Review.
Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity. Comment letter 2.
Peloquin C. Peloquin C. Antimicrob Agents Chemother. 2010 Jun;54(6):2750-1; author reply 2752. Antimicrob Agents Chemother. 2010. PMID: 20480959 No abstract available.
Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.
Pauly DJ, Musa DM, Lestico MR, Lindstrom MJ, Hetsko CM. Pauly DJ, et al. Pharmacotherapy. 1990;10(6):378-82. Pharmacotherapy. 1990. PMID: 2287556
The clinical utility of a published nomogram to predict aminoglycoside nephrotoxicity.
Lam YW, Arana CJ, Shikuma LR, Rotschafer JC. Lam YW, et al. JAMA. 1986 Feb 7;255(5):639-42. JAMA. 1986. PMID: 3944964
[Aminoglycoside nephrotoxicity and obstructive jaundice].
Lucena MI, Andrade RJ. Lucena MI, et al. Med Clin (Barc). 1995 Oct 14;105(12):457-60. Med Clin (Barc). 1995. PMID: 7490937 Review. Spanish. No abstract available.

See all similar articles

Cited by

Pharmacokinetic changes and dosing modification of aminoglycosides in critically ill obese patients: a literature review.
Velissaris D, Karamouzos V, Marangos M, Pierrakos C, Karanikolas M. Velissaris D, et al. J Clin Med Res. 2014 Aug;6(4):227-33. doi: 10.14740/jocmr1858w. Epub 2014 May 22. J Clin Med Res. 2014. PMID: 24883145 Free PMC article. Review.
Effects of obesity and sex on antimicrobial pharmacokinetics and acute kidney injury: validation of a preclinical model.
Pai MP, Chen WZ, Garba A, Cui H, Zaffo B, El-Fawal HA, Mousa SA. Pai MP, et al. Antimicrob Agents Chemother. 2013 Feb;57(2):716-22. doi: 10.1128/AAC.01194-12. Epub 2012 Nov 12. Antimicrob Agents Chemother. 2013. PMID: 23147732 Free PMC article.
Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.
Bearden DT, Rodvold KA. Bearden DT, et al. Clin Pharmacokinet. 2000 May;38(5):415-26. doi: 10.2165/00003088-200038050-00003. Clin Pharmacokinet. 2000. PMID: 10843460 Review.
Aminoglycoside therapy. Current use and future prospects.
Janknegt R. Janknegt R. Pharm Weekbl Sci. 1990 Jun 22;12(3):81-90. doi: 10.1007/BF01967600. Pharm Weekbl Sci. 1990. PMID: 2196530 Review.
Information provision for antibacterial dosing in the obese patient: a sizeable absence?
Boyd SE, Charani E, Lyons T, Frost G, Holmes AH. Boyd SE, et al. J Antimicrob Chemother. 2016 Dec;71(12):3588-3592. doi: 10.1093/jac/dkw324. Epub 2016 Aug 18. J Antimicrob Chemother. 2016. PMID: 27538956 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information